首页|苯磺酸瑞马与丙泊酚对老年患者术后谵妄的影响

苯磺酸瑞马与丙泊酚对老年患者术后谵妄的影响

扫码查看
目的 探究苯磺酸瑞马唑仑与丙泊酚对老年患者手术后谵妄发生率的影响的比较研究.方法 收集2021 年1 月至2023 年5 月接受冠状动脉搭桥手术或瓣膜置换术的180 例老年患者,随机分为苯磺酸瑞马唑仑组或丙泊酚组,每组 90 例.收集患者人口统计学信息;术后每 4 小时进行采用Richmond躁动-镇静评分(Richmond Agitation and Sedation Scale,RASS)评估镇静水平;采用通过视觉模拟评分(VAS)比较患者术后疼痛;使用重症监护谵妄筛查量表(Intensive Care Delirium Screening Checklist,ICDSC)评估谵妄发生情况;使用蒙特利尔认知评估(Montreal cognitive assessment,MoCA)量表评估术后认知能力;在手术过程中,调查人员记录所有不良事件,包括严重低血压和呼吸抑制.结果 2 组患者一般资料比较差异无统计学意义(P>0.05).苯磺酸瑞马唑仑组术后第 1 天、术后第 2 天和术后第 3天的谵妄发生率较丙泊酚组降低(P<0.05),术后统计发现,苯磺酸瑞马唑仑组合计共有 13 例发生谵妄,丙泊酚组共有 37 例发生谵妄,苯磺酸瑞马唑仑组谵妄率较丙泊酚组降低(14.44%vs 41.11%)(P<0.05).苯磺酸瑞马唑仑组术后第 1 天、术后第 2 天和术后第 3 天的每日谵妄严重程度评分较丙泊酚组降低(P<0.05),苯磺酸瑞马唑仑组平均谵妄评分较丙泊酚组降低P<0.05).察组术后第1 天、术后第2 天和术后第3 天的每日MoCA评分较丙泊酚组升高(P<0.05),苯磺酸瑞马唑仑组平均MoCA评分丙泊酚组升高P<0.05).静止状态下,2 组患者VAS评分比较无差异(P>0.05),当深呼吸或者身体运动时,苯磺酸瑞马唑仑组VAS评分较丙泊酚组降低(P<0.05).2 组患者不良事件发生率比较差异无统计学意义(P>0.05).结论 术中静脉注射苯磺酸瑞马唑仑可显著降低院内谵妄的发生率,减轻谵妄严重程度,改善术后疼痛.
A comparative study of the effects of Ramazolam benzoate versus propofol on the incidence of postoperative delirium in elderly patients
Objective To explore the influence of Ramazolam benzoate versus propofol on the incidence of postoperative delirium in elderly patients.Methods A total of 180 elderly patients who underwent coronary artery bypass grafting surgery or valve replacement surgery from January 2021 to May 2023 were recruited as the study subjects.They were randomly assigned to the Ramazolam benzoate group(n=90)and the propofol group(n=90).Demographic information was collected.After surgery,the level of sedation was assessed every 4 hours using the Richmond Agitation and Sedation Scale(RASS).The pain and delirium were assessed using the Visual Analog Scale(VAS)and the Intensive Care Delirium Screening Checklist(ICDSC),respectively.Postoperative cognitive ability was assessed using the Montreal Cognitive Assessment(MoCA)scale.During surgery,all adverse events,including severe hypotension and respiratory depression were recorded.Results There was no significant difference in the general data between the two groups(P>0.05).The incidence of delirium on day 1,2 and 3 after surgery in the Ramazolam benzoate group was significantly lower than that of the propofol group(P<0.05).Postoperative statistics showed 13 cases of delirium in the Ramazolam benzoate group and 37 cases in the propofol group.The delirium rate in the Ramazolam benzoate group was significantly lower than that of the propofol group(14.44%vs 41.11%,P<0.05).The daily delirium severity score on day 1,2 and 3 after surgery of the Ramazolam benzoate group was significantly lower than that of the propofol group(P<0.05).The mean delirium score of the Ramazolam benzoate group was significantly lower than that of the propofol group(P<0.05).The daily MoCA score on day 1,2 and 3 after surgery of the Ramazolam benzoate group was significantly higher than that of the propofol group(P<0.05),and the mean MoCA score of the Ramazolam benzoate group was significantly higher than that of the propofol group(P<0.05).There was no significant difference in the VAS score at rest between the two groups(P>0.05).The VAS score at deep breathing or physical exercise in the Ramazolam benzoate group was significantly lower than that of the propofol group(P<0.05).There was no significant difference in the incidence of adverse events between groups(P>0.05).Conclusion Intraoperative intravenous injection of Ramazolam benzoate can significantly reduce the in-hospital incidence of delirium,alleviate the severity of delirium,and improve postoperative pain.

Ramazolam benzoatepropofolelderly patientsheart surgerydelirium

田静朴、付美娟、孙昊、赵鹏

展开 >

065000 河北省廊坊市,河北中石油中心医院重症医学科

苯磺酸瑞马唑仑 二异丙酚 老年患者 心脏手术 谵妄

廊坊市科技支撑计划项目

2021013042

2024

河北医药
河北省医学情报研究所

河北医药

CSTPCD
影响因子:1.075
ISSN:1002-7386
年,卷(期):2024.46(4)
  • 20